Bio Special
Nebius Is Accelerating Drug Discovery with AI Infrastructure That Slashes Timelines from Years to Months
The traditional 7–10-year timeline for drug discovery is rapidly becoming obsolete. Thanks to advances in AI and compute infrastructure, pioneers lik...
August 04, 2025 | Interview
Johor’s Healthcare Transformation: Billions Poured into Malaysia’s Life Sciences Engine (2022–2025)
Johor’s Healthcare & Life Sciences Investment Boom (2022–2025) Over the past three years, the southern Malaysian state of Johor has emerge...
July 30, 2025 | Report
How Innovation Gaps in Biopharma Raise New Safety Concerns
The biopharmaceutical industry stands at the forefront of medical innovation and delivers remarkable advances in disease treatment and prevention. Breakthr...
July 24, 2025 | News
Precision Medicine – Are We Ready for It?
Sarthak Ranade, Area Managing Director of Johnson & Johnson Innovative Medicine for SEA and India, believes the era of precision medicine is no longer ...
July 23, 2025 | Opinion | By Sarthak Ranade, Area Managing Director, J&J Innovative Medicine, SEA & India
Smart Implants and the Future of Musculoskeletal Injury Treatment
While these methods are structurally effective, they cannot adapt to each patient's recovery process or provide insight into the progression of healing. Th...
July 21, 2025 | News
The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
The region’s women’s digital health market is projected to grow to $ 2,295.7 million by 2030, according to Grand View Research. This surge refl...
July 17, 2025 | News
Using NLP-Driven Decision Support in Emergency Health Assistance
According to the US Department of Transportation, over 40,000 lives were lost in roadway deaths in 2023. The CDC reports that the country saw appro...
July 14, 2025 | News
FDA Publishes First-Ever Public Database of Complete Response Letters (2020–2024) – Now Available for Download
Download Approved CRLs – 2020 to 2024 (external link) U.S. Food and Drug Administration (FDA) has, for the first time, made pub...
July 14, 2025 | Regulatory
Bio Investments Group and IVI Forge Strategic Alliance to Accelerate Vaccine Self-Reliance in Africa and the Middle East
The Bio Investments Group AG (BIG), a leading global healthcare-technology transfer platform, and the International Vaccine Institute (IVI), an internation...
July 14, 2025 | News
Unlocking Solubility as Lubrizol's Excipients Power the Next Generation of Drug Delivery
With up to 90% of new chemical entities suffering from poor water solubility, pharmaceutical innovators are under pressure to reformulate for eff...
July 09, 2025 | Interview
FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
The FDA’s recent decision to cut its workforce by 20 percent has raised concerns across the biopharma industry, with experts warning of inevitable de...
July 09, 2025 | Opinion | By Lindsay Mateo, Chief Commercial Officer at Weave Bio
Smarter Together: How Molecule GEN Transforms Cross-Functional Drug Discovery
This cloud-native, SaaS-based platform breaks down traditional barriers in drug discovery by uniting all disciplines—biology, chemistry, and computat...
July 07, 2025 | Opinion | By Saurabh Singal | CEO-Founder, Molecule AI
Southeast Asia Poised to Lead AI-Driven Healthcare Transformation Amid Rising Cross-Border Collaboration
The Southeast Asia (SEA) region’s role in healthcare innovation, long bolstered by Singapore’s commitment to serve as a g...
July 01, 2025 | Opinion | By Chu Canh Chieu, FPT Software Managing Director of Global Healthcare Center, FPT Corporation
India’s Life Sciences Industry Faces a Defining Moment Amid Shifting U.S. Drug Policies and Regulatory Scrutiny
India’s life sciences industry has grown at a remarkable pace over the past two decades, transforming into a global manufacturing powerhouse. Indian ...
June 25, 2025 | Opinion | By Sidley Austin partners Arif S. Noorani and Ryan Tan
Most Read
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
